Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Embera NeuroTherapeutics
company
About
Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $11M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$18.94M
Embera NeuroTherapeutics has raised a total of
$18.94M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2019 | Grant | — | 1 |
|
— | Detail |
| Jul 26, 2016 | Grant | $11M | 1 |
National Institutes of Health
|
— | Detail |
| Feb 26, 2015 | Series A | $2.34M | 1 | — | — | Detail |
| Aug 14, 2011 | Series A | $4.50M | 2 | — | — | Detail |
| Sep 15, 2008 | Series Unknown | $300K | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
5
Embera NeuroTherapeutics is funded by 5 investors.
Rose Research Center (RRC) in North Carolina
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
|
National Institutes of Health
|
Yes | Grant |
BVM Capital
|
— | Series A |
Louisiana Ventures
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
